Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06151717 · ClinicalTrials.gov registry record
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT06151717: Completed study, sponsored by Mayo Clinic.
NCT06151717 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06151717 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study evaluates the outcomes of patients undergoing initial therapy for multiple myeloma.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2025-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06151717
The ClinicalTrials.gov registry entry for NCT06151717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06151717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06151717 about?
NCT06151717 is a clinical study titled "A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma". This study evaluates the outcomes of patients undergoing initial therapy for multiple myeloma.
What is the current status of trial NCT06151717?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2023-09-21. Estimated completion is 2025-06-05.
What interventions are being tested in trial NCT06151717?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06151717?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.